Navigation Links
Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
Date:7/17/2012

NEW YORK, July 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise

http://www.reportlinker.com/p0935304/Multi-Targeted-Therapies---New-Wave-of-Combination-Therapies-in-Late-Stage-Development-for-Lung-Cancer-Offer-Promise.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

 

Summary

 

GBI Research, the leading business intelligence provider, has released its latest research, "Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise", which provides an overview of the discovery and development of therapeutic drug combinations and multi-target drugs for oncology. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report provides an insight into different methods and techniques used to identify and design drugs that act upon multiple targets in the treatment of cancer. It also focuses on the design and development of combination therapies to address multiple targets in oncology and the challenges surrounding this.

 

Pipeline analysis of the Phase III oncology pipeline focuses on indications such a lung cancer, breast cancer, colorectal cancer, prostate cancer, ovarian cancer, leukemia, lymphoma, head and neck cancer and multiple myeloma. The most common types of drug combinations used to treat these indications are highlighted and promising molecules in each i
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference
3. BioRestorative Therapies to Present at Marcum MicroCap Conference
4. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
5. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
6. Medivir Announces an Interferon-Free Phase II Combination Trial With TMC435 and daclatasvir to Commence Shortly
7. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
8. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
9. Seventeen Banner Health facilities achieve final stage of electronic medical record adoption
10. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
11. Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Russia,s ... The Pharma 2020 Strategy provides incentives for local producers ... and foreign markets. These trends, however, were affected by ... following political and economic sanctions imposed on ... Russia responded to the ...
(Date:9/16/2014)... 2014 Research and Markets ... Laparoscopy Devices Industry Report 2014" report to ... Devices Industry Report 2014 is a professional and ... global laparoscopic devices. The report provides ... classifications, applications and industry chain structure. The laparoscopic ...
(Date:9/16/2014)... Sept. 16, 2014 Based on its ... Frost & Sullivan recognises Incisive Surgical with the ... Value Leadership. Incisive Surgical,s uniquely-designed, innovative INSORB® Absorbable ... eliminates the need for patients to undergo the ... removal  that may result in increased pain, wound ...
Breaking Medicine Technology:Global Medicines for Russia 2Global Laparoscopy Devices Industry Report 2014 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5
(Date:9/16/2014)... (PRWEB) September 16, 2014 Transparency Market ... that the global facial care market is expected to ... The report, titled ‘Facial Care Market (By Product Type ... Wash, Cleansing Wipes, Serums and Masks and Others (fade ... Share, Growth, Trends and Forecast 2013 – 2019,’ is ...
(Date:9/16/2014)... 2014 Whatisfinalexpenseinsurance.com has released a ... affordable life insurance for seniors. , Finding affordable life ... A big part of the insurance market has moved ... tips that clients can use when shopping for life ... is important for providing financial security for vulnerable family ...
(Date:9/16/2014)... is effective in diagnosing concussion-related brain disease while a ... conducted at the Icahn School of Medicine at Mount ... Haven, and published September 16 in the journal ... that an experimental radiolabeled compound called [18 F]-T807, which ... that accumulates in the brain with repetitive blows to ...
(Date:9/16/2014)... Researchers at the Hebrew University of Jerusalem have ... at coaxing adult cells to become quality pluripotent ... and expanding area that aims to replace lost ... transplantation. Because stem cells derived from human embryos ... reprogramming adult cells back to an embryo-like state ...
(Date:9/16/2014)... Gary F. Locke, the former U.S. Ambassador to ... Group for exclusive representation of his global speaking activities. ... of Washington, Locke is widely recognized as one of ... and business growth. , “Gary Locke provides audiences with ... an organization’s global presence in and with China,” stated ...
Breaking Medicine News(10 mins):Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 2Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 3Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 3Health News:Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... cells in the human brain is linked to learning and ... Florida. The research is the first to show such a ... upcoming print issue of the journal Brain , provide ... and reveal potential cellular targets for drug therapy. The ...
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- ... 2008, nearly one in four American parents with health insurance ... to access the medical care their children needed. Parents ... likely than others to say their insurance coverage did not ...
... Despite the fact that an estimated 25 million ... general anesthesia, scientists have only been able to hypothesize ... They previously thought that the processes of "going under" ... the same way. Now, researchers at the University of ...
... Va.SNM supports the U.S. Senate in its introduction of ... and Radiation Therapy Act of 2010 (CARE Act), S. ... by Sen. Mike Enzi [R-WY], aims to ensure that ... are set at the state level. The bill,s co-sponsors ...
... Melissa Lee Phillips HealthDay Reporter , WEDNESDAY, Aug. ... to an inheritable eye disease that affects 5 percent of ... for transplants of the cornea. The genetic disorder, ... the cornea -- the thin, clear membrane that covers the ...
... Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- U.S. ... U.S. judge to halt any expansion of stem cell ... basically blindsided the scientific community, effectively takes embryonic stem ... when then-President George W. Bush ordered that federal monies ...
Cached Medicine News:Health News:Scientists find link in humans between nerve cell production, memory 2Health News:Scientists find link in humans between nerve cell production, memory 3Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 2Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 3Health News:Penn study sheds light on how the brain shifts between sleep/awake states under anesthesia 2Health News:SNM applauds US Senate's introduction of CARE Act 2Health News:Study Links Gene to Serious Eye Disease 2Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: